Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

First Potential Lupus-Specific Treatment In Sight
Today, Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from a year-long clinical trial of BENLYSTA for treating lupus. When the 52-week study concluded, the lupus patients who were treated with BENLYSTA had improvement in overall disease activity without clinically significant flare-ups in one or more isolated organs when compared to patients who received the placebo (inactive agent). The patients receiving BENLYSTA also were able to reduce their intake of steroid medications. The study is the largest ever to be completed for lupus and the first Phase III (late stage) trial of a new biologic immune therapy for lupus to succeed in meeting its primary endpoint and most of its secondary endpoints.
generic viagra online
Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely In Re-Limited Settings Without Routine Laboratory Monitoring
Gilead Sciences, Inc. (Nasdaq:GILD) highlighted results from a study known as DART (Development of Anti-Retroviral Treatment in Africa), which evaluated the need for routine laboratory monitoring in adults taking antiretroviral therapy in Africa. The DART trial was an open-label, randomized study comparing clinical and laboratory monitoring to clinical monitoring alone for efficacy and toxicity. In this study, 74 percent of patients were on a treatment regimen containing Viread® (tenofovir disoproxil fumarate). At baseline, more than 50 percent of patients had reduced renal function. The results indicated that Viread was well tolerated and that the incidence of renal adverse events was low. DART researchers concluded that renal function test results were similar in both arms of the trial for up to five years, suggesting that routine monitoring of Viread may not be necessary in re-limited settings when using the product as part of a first-line HIV treatment regimen. The results of the study were presented today at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) in Cape Town, South Africa.
News of the day
Disparity In Sex Ratio Increases In Vietnam
Sex-selective abortion among families in Vietnam with a cultural preference for boys has contributed to a sex ratio of 112 male infant births for every 100 female births in the country, according to a government official, the AP/Yahoo! News reports. According to the AP/Yahoo! News, many doctors in Vietnam do not comply with a 2003 law prohibiting the disclosure of a fetus" sex. Duong Quoc Trong, deputy director of the General Office for Population and Family Planning, said that the birth rate in 1999 was considered close to the natural rate, with about 107 boys born for every 100 girls. Since 2006, the ratio of boys to girls has steadily increased and approached a rate similar to China"s imbalance 20 years ago, he said.Trong added that the government intends to more strictly enforce the country"s ban on sex-selective abortion. The Ministry of Health recently confiscated more than 2,600 books that claim to describe ways to conceive a male child, such as special diets, MOH Deputy Chief Inspector Nguyen Dingh Bach said. He added that the ministry also ordered seven Web sites to remove articles describing such methods (AP/Yahoo! News, 7/2).
Mental Health

Senate GOP Escalates Criticism Of Supreme Court Nominee Sotomayor In Speeches

Senate Republicans on Tuesday in the first in a series of floor addresses launched more strongly worded criticism of Supreme Court nominee Judge Sonia Sotomayor"s judicial record and previous speeches, Politico reports. Although the floor speeches are not likely to undermine the Democratic majority"s support for Sotomayor or block her confirmation, they indicate a shift in strategy for the GOP as it tries to generate more opposition to the nomination, according to Politico. As senators approach the weeklong July 4 recess, Republicans are attempting to show that they have "no intention of lying down in the face of what appears to be an increasingly inevitable confirmation," Politico reports. Senate Minority Leader Mitch McConnell (R-Ky.), Senate Judiciary Committee ranking Republican Jeff Sessions (Ala.) and Sen. John Cornyn (R-Texas) used their time on the Senate floor to attempt to portray Sotomayor as a "judicial activist" and to attack President Obama"s previous statements that he would like to appoint a judge who displays "empathy" (Isenstadt, Politico, 6/24). Republicans also reiterated they will attempt to delay Sotomayor"s confirmation hearing, scheduled to begin July 13, if they do not feel they have enough time to review her judicial record, Roll Call reports. They also questioned Sotomayor"s involvement with the civil rights group LatinoJustice PRLDEF, which they labeled "far left," taking up a line of criticism that other conservatives have pushed. Sotomayor served as a board member for the group from 1980 to 1992. Democrats and White House officials are aggressively defending Sotomayor"s record, arguing that her lengthy judicial career supersedes any public statements or speeches she made in the past, according to Roll Call. Both said that their strategy is to avoid a point-counterpoint argument with Republicans. A White House official said there is "no reason to speculate on her record," which includes more than 3,000 panel decisions. Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) said that he has been "struck by her extraordinary career and how she"s excelled at everything she"s done." Leahy said that he is not convinced that Republicans need more time, noting that the Senate is using the same confirmation timetable as it used for Chief Justice John Roberts. Although Leahy said that he might be willing to discuss a schedule change if Republicans agreed not to filibuster or delay the nomination, he added that Republicans have not suggested such a deal at this point (Stanton, Roll Call, 6/24). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009